Integra Lifesciences Holdings (IART) Total Liabilities (2009 - 2026)

Integra Lifesciences Holdings' Total Liabilities history runs 18 years deep, the most recent figure standing at $2.5 billion for Q1 2026.

• In Q1 2026, Total Liabilities changed 0.27% year-over-year to $2.5 billion; the TTM figure through Mar 2026 stood at $2.5 billion (changed 0.27% YoY), while the FY2025 annual figure was $2.6 billion, up 2.66% from the prior year.
• Total Liabilities came in at $2.5 billion for Q1 2026 at Integra Lifesciences Holdings, down from $2.6 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $2.6 billion in Q2 2025 to a low of $2.1 billion in Q1 2022.
• A 5-year average of $2.3 billion and a median of $2.5 billion in 2024 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities fell 7.03% in 2022 and rose 21.29% in 2024, its largest moves.
• Integra Lifesciences Holdings' Total Liabilities stood at $2.1 billion in 2022, then climbed by 5.21% to $2.2 billion in 2023, then climbed by 13.58% to $2.5 billion in 2024, then rose by 2.66% to $2.6 billion in 2025, then declined by 0.91% to $2.5 billion in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $2.5 billion, $2.6 billion, and $2.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison